Publisher's note channel feed

End­points News is now 5 years old. Here's how you can sup­port us for the next phase of growth

Last month

The CHIC in­ter­view: Stéphane Ban­cel on Mod­er­na's overnight trans­for­ma­tion, the new time­line on vac­cine de­vel­op­ment and his one re­gret in 2020

3 months ago
People

In­tro­duc­ing End­points FDA+, our new pre­mi­um week­ly reg­u­la­to­ry news re­port led by Zachary Bren­nan

4 months ago

What’s next for End­points — and how to sup­port our in­de­pen­dent bio­phar­ma news mis­sion

6 months ago

The End­points 11 cel­e­brates bio­phar­ma's most promis­ing star­tups. Live event on Sep­tem­ber 30

11 months ago

How you can help us grow End­points News through the pan­dem­ic

Last year

Video Re­play: End­points at #JPM20 — news­mak­ers on deal­mak­ing, pric­ing and man­u­fac­tur­ing

Last year

Un­lock the full End­points ex­pe­ri­ence for your com­pa­ny — and sup­port our mis­sion of in­de­pen­dent bio­phar­ma re­port­ing

Last year

About the re­designed End­points News

3 years ago

An up­date on the End­points busi­ness mod­el — and how your com­pa­ny can di­rect­ly sup­port it

3 years ago

Let's go to Chi­na: Join End­points in Shang­hai for the first US-Chi­na Bio­phar­ma In­no­va­tion & In­vest­ment Sum­mit — Oc­to­ber 22-23 #BI­IS18

3 years ago
China

End­points' Chi­na cov­er­age is get­ting deep­er. An­nounc­ing our part­ner­ship with Pharm­Cube, the lead­ing Chi­nese bio­phar­ma da­ta provider

4 years ago
China

In­sti­tu­tion­al re­search is flawed. I'm team­ing with End­points to help de­moc­ra­tize it

4 years ago
Pharma

Hir­ing? How End­points can help your com­pa­ny fill open po­si­tions with our tal­ent­ed read­ers

4 years ago
Peer Review

Putting your sub­scrip­tion dol­lars to use: San Diego-based Brit­tany Meil­ing is join­ing End­points News

4 years ago

How En­ter­prise cus­tomers can get End­points News in­to their Slack

4 years ago

How your com­pa­ny can fund the work at End­points News — and give your em­ploy­ees com­plete ac­cess to our con­tent

4 years ago